Self-assembled luminous current-conducting nano medicine crystal and ultra-thin film and preparation method thereof
A nano drug crystal, conductive nano technology, applied in the direction of nano technology, nano technology, drug combination, etc., can solve the problem of heart, lung and brain hypoxic damage without defense
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0040] Prepare the following medicinal solution according to the Pharmacopoeia specification issued by the Ministry of Health of the People's Republic of China:
[0041] 1. Preparation of Ibopridine Hydrochloride Solution 2.5 mg / 5 mL
[0042] 2. Prepare a solution containing 2 mg / 100 ml of isoproterenol hydrochloride
[0043] 3. Preparation of Physiological Salt Buffer Containing 1 mg / 2 mL Superoxide Dismutase
[0044] 4. Preparation of Physiological Salt Buffer Containing 20 mg / 3.3 mL ATP
[0045] 5. Take the solute number of each component within the concentration range of 1:3:3:3, mix evenly at room temperature, add physiological saline buffer solution to 1 ml, store at -4°C for later use.
[0046] 6. Use graphite and silicon wafers as the substrates of self-assembled crystals and their ultra-thin films, drip the above-mentioned 5 μL medicinal components on the graphite and silicon wafer substrates according to the L16(2)15 and L9(3)4 schemes, place -4°C for 12 hours.
Embodiment 2
[0048] Prepare the following medicinal solution according to the Pharmacopoeia specification issued by the Ministry of Health of the People's Republic of China:
[0049] 1. Preparation of Ibopridine Hydrochloride Solution 2.5 mg / 5 mL
[0050] 2. Prepare a solution containing 2 mg / 100 ml of isoproterenol hydrochloride
[0051] 3. Preparation of Physiological Salt Buffer Containing 1 mg / 2 mL Superoxide Dismutase
[0052] 4. Preparation of Physiological Salt Buffer Containing 20 mg / 3.3 mL ATP
[0053] 5. Take the solute number of each component within the concentration range of 2:3:1:2, mix evenly at room temperature, add physiological saline buffer solution to 1 ml, store at -4°C for later use.
[0054] 6. Use graphite and silicon wafers as the substrates of self-assembled crystals and their ultra-thin films, drip the above-mentioned 5 μL medicinal components on the graphite and silicon wafer substrates according to the L16(2)15 and L9(3)4 schemes, place -4°C for 12 hours.
Embodiment 3
[0056] Prepare the following medicinal solution according to the Pharmacopoeia specification issued by the Ministry of Health of the People's Republic of China:
[0057] 1. Preparation of Ibopridine Hydrochloride Solution 2.5 mg / 5 mL
[0058] 2. Prepare a solution containing 2 mg / 100 ml of isoproterenol hydrochloride
[0059] 3. Preparation of Physiological Salt Buffer Containing 1 mg / 2 mL Superoxide Dismutase
[0060] 4. Preparation of Physiological Salt Buffer Containing 20 mg / 3.3 mL ATP
[0061] 5. Take the solute number of each component within the concentration range of 0:1:1:1, mix evenly at room temperature, add physiological saline buffer solution to 1 ml, store at -4°C for later use.
[0062] 6. Use graphite and silicon wafers as substrates for self-assembled crystals and their ultra-thin films, drop 5 μL of the above medicinal components on the graphite and silicon wafer substrates according to the schemes L16(2)15 and L9(3)4, and place -4°C for 12 hours.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com